1.91
price down icon5.91%   -0.12
after-market After Hours: 1.92 0.01 +0.52%
loading
Mustang Bio Inc stock is traded at $1.91, with a volume of 274.82K. It is down -5.91% in the last 24 hours and up +85.44% over the past month. Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$2.03
Open:
$2.02
24h Volume:
274.82K
Relative Volume:
0.05
Market Cap:
$6.75M
Revenue:
-
Net Income/Loss:
$-23.42M
P/E Ratio:
-0.0245
EPS:
-78
Net Cash Flow:
$-16.67M
1W Performance:
-12.39%
1M Performance:
+85.44%
6M Performance:
-60.13%
1Y Performance:
-89.07%
1-Day Range:
Value
$1.90
$2.0885
1-Week Range:
Value
$1.90
$2.1899
52-Week Range:
Value
$0.8926
$21.95

Mustang Bio Inc Stock (MBIO) Company Profile

Name
Name
Mustang Bio Inc
Name
Phone
(781) 652-4500
Name
Address
377 PLANTATION STREET, WORCESTER, NY
Name
Employee
6
Name
Twitter
@Mustang_Bio
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
MBIO's Discussions on Twitter

Compare MBIO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MBIO
Mustang Bio Inc
1.91 8.89M 0 -23.42M -16.67M -78.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 31.91B 3.81B -644.79M -669.77M -6.24

Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades

Date Action Analyst Rating Change
May-18-21 Initiated BTIG Research Buy
Oct-02-20 Initiated B. Riley FBR Buy
Nov-20-19 Initiated Cantor Fitzgerald Overweight
Aug-13-19 Initiated H.C. Wainwright Buy
Jun-21-19 Initiated Cantor Fitzgerald Overweight
Dec-21-17 Initiated Oppenheimer Outperform
View All

Mustang Bio Inc Stock (MBIO) Latest News

pulisher
Jul 24, 2025

What analysts say about Mustang Bio Inc. stockOverwhelming financial success - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Mustang Bio Inc. Stock Analysis and ForecastOutstanding stock performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Mustang Bio Inc. stock priceExceptional gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Mustang Bio Inc. a good long term investmentExceptional risk-adjusted gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 19, 2025

Mustang Bio (NASDAQ:MBIO) Upgraded to “Hold” at Wall Street Zen - Defense World

Jul 19, 2025
pulisher
Jul 15, 2025

How Mustang Bio Inc. stock performs during market volatility200 Percent Gain Alert - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Mustang Bio Inc. stock attracts strong analyst attentionSafe Entry High Exit Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Mustang Bio Inc. stock price move sharplyTriple Digit Return Forecasts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

MBIO Stock: Exploring Mustang Bio Inc’s Growth - investchronicle.com

Jul 15, 2025
pulisher
Jul 09, 2025

Mustang Bio Shares Skyrocket After Orphan Drug Designation - StocksToTrade

Jul 09, 2025
pulisher
Jul 09, 2025

Mustang Bio’s Shares Skyrocket as FDA Grants Orphan Drug Designation - timothysykes.com

Jul 09, 2025
pulisher
Jul 09, 2025

Promising Small Cap Stocks Worth Watching – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Top Penny Stocks To Follow Now – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Mustang Bio’s Meteoric Surge: What’s Driving Up MBIO? - StocksToTrade

Jul 09, 2025
pulisher
Jul 09, 2025

Mustang Bio’s Stock Soars: What’s Driving the Surge? - timothysykes.com

Jul 09, 2025
pulisher
Jul 09, 2025

Mustang Bio Receives FDA Orphan Drug Designation - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

Best Medical Stocks To Follow Today – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Promising Pharmaceutical Stocks To Consider – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Top Biotech Stocks To Research – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On - Benzinga

Jul 09, 2025
pulisher
Jul 08, 2025

Mustang Bio Ignites Bullish Retail Buzz As FDA Grants Orphan Status To Brain Cancer Drug - NewsBreak: Local News & Alerts

Jul 08, 2025
pulisher
Jul 08, 2025

MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - TradingView

Jul 08, 2025
pulisher
Jul 08, 2025

Mustang Bio Stock Jumps 180% After FDA Grants Orphan Drug Status to Brain Cancer Drug - inkl

Jul 08, 2025
pulisher
Jul 08, 2025

Why Did Mustang Bio Plunge 11.68% After 196.21% Surge? - AInvest

Jul 08, 2025
pulisher
Jul 08, 2025

Biotech Stock Analysis: MBIO Soars after FDA Grants Orphan Drug Designation - Markets.com

Jul 08, 2025
pulisher
Jul 07, 2025

Market Wrap | US Stocks Slide as Fed Rate Cut Hints Emerge Palantir and Mustang Bio Soar - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Mustang Bio (MBIO) Stock Explodes 260% After FDA Grants Key Cancer Drug Designation - Benzinga

Jul 07, 2025
pulisher
Jul 07, 2025

Dow Dips 1%; Mustang Bio Shares Spike Higher - inkl

Jul 07, 2025

Mustang Bio Inc Stock (MBIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):